CERAH NAGATA: Open Payments
NPI 1427648435 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$541 in 5 payments from 4 companies in 2025. Trend: 2023 $318 · 2024 $437 · 2025 $541
Food & beverage: $541
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $172 |
| Otsuka America Pharmaceutical, Inc. | 1 | $127 |
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| Alkermes, Inc. | 2 | $120 |
Products named: INGREZZA, REXULTI, COBENFY, LYBALVI.
Industry payments across CA — which companies pay providers there.
